SynthesisBMC cancer2022

Adverse effects in hematologic malignancies treated with chimeric antigen receptor (CAR) T cell therapy: a systematic review and Meta-analysis.

Wenjing Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.